A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia

Molecular Psychiatry

Volumn 3, Issue 2, 1998, Pages 141-149

  Williams, J ^a   Spurlock, G ^a   Holmans, P ^a   Mant, R ^b   Murphy, K ^a   Jones, L ^a   Cardno, A ^a   Asherson, P ^c   Blackwood, D ^d   Muir, W ^d   Meszaros, K ^e   Aschauer, H ^e   Mallet, J ^f   Laurent, C ^f   Pekkarinen, P ^g   Seppala, J ^g   Stefanis, C N ^h   Papadimitriou, G N ^h   Macciardi, F ⁱ   Verga, M ⁱ   Pato, C ^j   Azevedo, H ^j   Crocq, M A ^k   Gurling, H ^l   Kalsi, G ^l   Curtis, D ^l   McGuffin, P ^a   Owen, M J ^a   more..

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁱ UNIVERSITY OF MILAN   (Italy)

^j UNIVERSITY OF COIMBRA   (Portugal)

^k Research in Psychiatry   (France)

^l ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

more..

Author keywords

Association; D3 receptor gene; Meta analysis; Schizophrenia; TDT

Indexed keywords

DOPAMINE 3 RECEPTOR;

ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RECEPTOR GENE; SCHIZOPHRENIA;

EID: 6844222858     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000376     Document Type: Article

References (62)

1. Farmer AE, McGuffin P, Gottesman II. Twin concordance for DSM-III schizophrenia: scrutinising the validity of the definition. Arch Gen Psychiatry 1987; 44: 864-870.
2. McGuffin P, Owen MJ, Farmer AE. The genetic basis of schizophrenia. Lancet 1995; 346: 678-682.
3. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 1989; 46: 222-228.
4. McGue M, Gottesman II. Genetic linkage in schizophrenia; perspectives from genetic epidemiology. Schiz Bull 1989; 15: 453-464.
5. O'Rourke DH, Gottesman II, Suarez BK, Rice J, Reich T. Refutation of the single-locus model of the etiology of schizophrenia. Am J Hum Genet 1982; 34: 630-649
6. Plomin R. The role of inheritance in behaviour. Science 1990; 248: 183-188.
7. Gottesman H, Shields JA. Polygenic theory of schizophrenia. Proc Natl Acad Sci 1990; 58: 199-205.
8. Morton NE. Outline of Genetic Epidemiology. Karger: Basel, 1982.
9. Owen MJ, McGuffin P. The genetics of schizophrenia: future directions. Schizophrenia Monitor 1996; 6: 1-4.
10. Williams J, Owen MJ, Spurlock G, McGuffin P. Searching for susceptibility genes for schizophrenia: The European Multicentre Association Study. New Trends Exp Clin Psychiatry 1995; 11: 1.
11. Seeman P, Chau-Wong M, Tedesco J, Wong K. Brain receptors for antipsychotic drugs and dopamine. Direct binding assays. Proc Acad Sci USA 1975; 72: 4376-4380.
12. Sokoloff P, Lannfeldt L, Martres MP, Giros B, Bouthenet ML, Schwartz JC. The D3 dopamine receptor gene as a candidate gene for genetic linkage studies. In: Mendlewicz J, Hippus H (eds). A Genetic Research in Psychiatry. Springer-Verlag: Berlin, 1992, pp 135-145.
13. Sokoloff P, Girus B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterisation of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990; 347: 146-151.
14. Sunahara RK, Guan HC, O'Dowd BS, Suman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HH, Niznik HB. Cloning of the gene for a D5 receptor with higher affinity for dopamine and D1. Nature 1991; 350: 614-619.
15. Van Tol HHM, Bunzow JR, Guan HC, Sunahara RK, Suma P, Niznik HB et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the anti-psychotic clozapine. Nature 1991; 250: 610-614.
16. Jernigan TL. Neuroanatomical factors in schizophrenia. In: Kavanagh DJ (ed). Schizophrenia: An Overview and Practical Handbook. Chapman & Hall: London, 1992.
17. Buckland PR, O'Donovan MC, McGuffin P. Clozapine and sulpiride upregulate dopamine D3 receptor mRNA levels. Neuropharmacology 1993; 32: 901-907.
18. Buckland PR, O'Donovan MC, McGuffin P. Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment. Psychopharmacology 1992; 106: 479-483.
19. Srivasta LK, Morency MA, Bajwa SB, Mishra RK. Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain. J Mol Neurosci 1990; 2: 155-161.
20. Accili D, Simone Fishburn C, Drago J et al. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci 1996; 93: 1945-1949.
21. Le Conait M, Sokoloff P, Hillion J, Matres MP, Giros B, Pilon C et al. Chromosomal localization of the human dopamine D3 receptor gene. Hum Genet 1991; 87: 618-620.
22. Lannfelt L, Sokoloff P, Martres M, Pilon C, Giros B, Jonsson E et al. Amino-acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr Genet 1992; 2: 249-256.
23. 3 receptor with the Semliki forest virus system. Biochem Biophys Res Commun 1996; 225: 1068-1072.
24. Coon H, Byerley W, Holik J, Hoff M, Myles-Worsley M, Lannfelt L et al. Linkage analysis between schizophrenia and 5 dopamine receptors. Am J Hum Genet 1993; 52: 327-334.
25. Crocq M-A, Mant R, Asherson P, Williams J, Hode Y, Mayerova A et al. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 1992; 29: 858-860.
26. Mant R, Williams J, Asherson P, Parfitt E, McGuffin P, Owen MJ. Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia. Am J Med Genet 1994; 54: 21-26.
27. Nimgaonkar VL, Zhang XR, Caldwell JG, Ganguli R, Chakravarti A. Association study of schizophrenia with dopamine D3 receptor gene polymorphisms probable effects of family history of schizophrenia? Am J Med Genet 1993; 48: 214-217.
28. Jonsson E, Lannfelt L, Sokoloff P, Schwartz JC, Sedrall G. Lack of association between schizophrenia and alleles of the D3 receptor gene. Acta Psychiatr Sacnd 1993; 87: 345-349.
29. Nimgaonkar VL, Zhang XR, Brar JS, Hogge WA, Ganguli R, Chakravarti A. Dopamine D3 receptor gene locus: association with schizophrenia, as well as age of onset. Am J Hum Genet 1994; 55: 3-A160.
30. Nothen MM, Cichon S, Propping P. Excess of homozygosity at the dopamine D3 receptor gene in schizophrenia confirmed. J Med Genet 1993; 30: 708.
31. Yang L, Li T, Wiese C, Lannfelt L, Sokoloff P, Xu CT et al. No association between schizophrenia and homozygosity at the D3 dopamine receptor gene. Am J Med Genet 1993; 48: 83-86.
32. Laurent C, Savoye C, Samolyk D, Mallet J. Homozygosity at the D3 receptor locus is not associated with schizophrenia. J Med Genet 1994; 31: 260.
33. Hawi Z, Straub RE, O'Neill A et al. No linkage or association between schizophrenia and the dopamine D3 receptor polymorphism. Am J Med Genet 1997; 74: 625.
34. McGue M, Gottesman II, Ran DC. The transmission of schizophrenia under a multifactorial threshold model. Am J Hum Genet 1983; 35: 1161-1178.
35. Spielman RS, McGinnis RE, Ewenst WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
36. Schaid DJ, Sommer SS. Comparison of statistics for candidate-gene association studies using cases and parents. Am J Hum Genet 1994; 55: 402-409.
37. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251-253.
38. Cohen J. Statistical Power Analysis for the Behavioural Sciences (2nd edn). Lawrence Erlbaum Associates: Hillsdale, NJ, 1998.
39. McGuffin P, Farmer AE, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991; 48: 764-770.
40. Williams J, Farmer AE, Ackenheil M, Kaufmann CA, McGuffin P et al. A multicentre inter-rater reliability study using the OPCRIT computerised diagnostic system. Psychol Med 1996; 26: 775-783.
41. Spielman RS, Ewens W. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996; 59: 983-989.
42. Asherson P, Mant R, Holmans P, Williams J et al. Linkage, association and mutation analysis at the dopamine D3 receptor gene in schizophrenia. Mol Psychiatry 1996; 1: 125-132.
43. Spurlock G, Williams J, McGuffin P et al. European multi-centre association study of schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. Am J Med Genet Neuropsych Genet (in press).
44. Saha N, Tsoi WF, Low PS et al. Lack of association of the dopamine D3 receptor gene polymorphism (BalI) in Chinese schizophrenic males. Psychiatric Genet 1994; 4: 201-204.
45. Rietschell M, Nothen MM, Albus M et al. Dopamine D3 receptor Gly(9)/SER(9) polymorphism and schizophrenia - no increased frequency of homozygosity in German familial cases. Schiz Res 1994; 20: 181-186.
46. Shaikh S, Collier DA, Sham PC et al. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Hum Genet 1996; 97: 714-719.
47. Griffon N, Crocq MA, Pilon C et al. Dopamine D3 receptor gene - organization, transcript variants and polymorphism associated with schizophrenia. Am J Med Genet 1995; 67: 63-70.
48. Nimgaonkar AR, Sanders R, Ganguli XR et al. Association study of schizophrenia and the dopamine D3 receptor gene locus in two independent samples. Am J Med Genet (Neuropsychiatric Genet) 1996; 67: 505-514.
49. Nanko S, Sasaki T, Fukuda R et al. A study of the association between schizophrenia and the dopamine D3 receptor gene. Hum Genet 1993; 92: 336-338.
50. Inada T, Sugita T, Dobashi I et al. Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients. Psychiatric Genet 1994; 5: 113-116.
51. Ebstein RB, Macciardi F, Blaine D et al. Positive association between a DRD3 exon 1 polymorphism (Mscl) and schizophrenia in an Israeli non-Ashkenazi population. Psychiatric Genet 1995; 5: S13.
52. DiBella D, Catalano M, Strukel M et al. Distribution of the Mscl polymorphism of the dopamine D3 receptor in an Italian psychotic population. Psychiatr Genet 1994; 4: 39-42.
53. Kennedy JL, Billett EA, Macciardi FM et al. Association study of dopamine D3 receptor gene and schizophrenia. Am J Med Genet 1995; 60: 558-562.
54. Maziadi M, Martinez M, Roy MA et al. Childhood onset and adult onset schizophrenia (SZ): comparative pilot data on DRD3. Biol Psychiatry 1997; 170: 27-30.
55. Gaitonde EJ, Morris A, Sivagnanasundaram S et al. Assessment of association of D3 dopamine receptor Mscl polymorphism with schizophrenia: analysis of symptom ratings, family history, age at onset, and movement disorders. Am J Med Genet (Neuropsych Genet) 1996; 67: 455-458.
56. Durany N, Thome J, Palomo A et al. Homozygosity at the dopamine D3 receptor gene in schizophrenic patients. Neurosci Lett 1996; 220: 151-154.
57. Cagle M, Peacock ML, Mathay JG et al. Dopamine D3 receptor polymorphism in schizophrenia: importance of evaluating control subjects. Am J Hum Genet 1993; 53: 788.
58. Tanaka T, Igarashi S, Onodera O, Tanaka H, Takahashi M, Maeda M et al. Association study between schizophrenia and dopamine D3 receptor polymorphisms. Am J Med Genet 1996; 366-368.
59. Kalsi G, Curtis D, Brynjolfsson J et al. A linkage study between a D3 dopamine receptor (DRD3) gene polymorphism and schizophrenia. Am J Med Genet 1997; 74: 626.
60. Krebs MO, Sautel F, Bourdel MC et al. Dopamine D3 receptor gene variants and pharmacosensitive schizophrenic patients. Am J Med Genet 1997; 74: 626.
61. Beckman L, Frohlander N. Heterozygosity effects in studies of genetic markers in disease. Hum Hered 1990; 40: 322-329.
62. Windl O, Dempster M, Estibeiro JP et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum-Genet 1996; 98: 259-264.